Chemoinformaics analysis of 8-TRANS-PIPERAMIDE-C-9-1
| Molecular Weight | 329.44 | nRot | 8 |
| Heavy Atom Molecular Weight | 302.224 | nRig | 17 |
| Exact Molecular Weight | 329.199 | nRing | 3 |
| Solubility: LogS | -4.821 | nHRing | 2 |
| Solubility: LogP | 4.58 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 51 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 27 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 54.9094 |
| nHD | 0 | BPOL | 33.1366 |
| QED | 0.664 |
| Synth | 2.206 |
| Natural Product Likeliness | 0.179 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.987 |
| Pgp-sub | 0.013 |
| HIA | 0.001 |
| CACO-2 | -4.824 |
| MDCK | 0.0000297 |
| BBB | 0.898 |
| PPB | 0.970601 |
| VDSS | 1.11 |
| FU | 0.0300793 |
| CYP1A2-inh | 0.952 |
| CYP1A2-sub | 0.297 |
| CYP2c19-inh | 0.865 |
| CYP2c19-sub | 0.221 |
| CYP2c9-inh | 0.596 |
| CYP2c9-sub | 0.754 |
| CYP2d6-inh | 0.942 |
| CYP2d6-sub | 0.887 |
| CYP3a4-inh | 0.954 |
| CYP3a4-sub | 0.176 |
| CL | 13.084 |
| T12 | 0.36 |
| hERG | 0.53 |
| Ames | 0.005 |
| ROA | 0.025 |
| SkinSen | 0.971 |
| Carcinogencity | 0.562 |
| EI | 0.101 |
| Respiratory | 0.636 |
| NR-Aromatase | 0.277 |
| Antiviral | Yes |
| Prediction | 0.726075 |